检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:阚庆辉 童富云[1] 徐美玲[1] 孙荣华[1] 黄波 KAN Qinghui;TONG Fuyun;XU Meiling;SUN Ronghua;HUANG Bo(Department of Breast Thyroid Vascular Surgery,Chongqing Fuling Central Hospital,Chongqing 408000,China)
出 处:《重庆医学》2019年第23期4009-4011,4016,共4页Chongqing medicine
摘 要:目的 分析外周静脉穿刺中心静脉置管(PICC)与完全置入式输液港(TIVAP)在乳腺癌化疗中的差异,为乳腺癌患者提供合适的选择。方法 选取2014年7月至2018年9月在该院行化疗的乳腺癌患者170例,其中经健侧上肢置入PICC患者90例(PICC组),TIVAP置入患者80例(TIVAP组),比较两组手术时间、留置时间、并发症发生情况。结果 TIVAP组手术时间、导管留置时间较PICC组长,差异均有统计学意义(P<0.05);TIVAP组血栓、局部感染、纤维鞘、疼痛的发生率及并发症总发生率低于PICC组,差异均有统计学意义(P<0.05);两组导管异位、血行感染、导管贴壁的发生率比较,差异均无统计学意义(P>0.05)。结论 TIVAP相比PICC具有更少的并发症,更长的留置时间,是大部分乳腺癌患者化学治疗药物输注的良好选择。Objective To analyse the differences between peripherally inserted central catheter(PICC)and totally implantable venous-access port(TIVAP)in chemotherapy for breast cancer,so as to provide an appropriate option for patients with breast cancer.Methods A total of 170 cases of patients with breast cancer who had received chemotherapy in this hospital from July 2014 to September 2018 were enrolled,including 90 cases of patients received PICC(PICC group)and 80 cases of patients received with TIVAP(TIVAP group).The operation time,catheter indwelling time and complications of the two groups were compared.Results The operation time and catheter indwelling time in the TIVAP group were significantly longer than those in the PICC group,there were statistically significant differences(P<0.05).The incidence rate of thrombosis,local infection,fibrous sheath formation and pain and the total incidence rate of complications in the TIVAP group were lower than those in the PICC group,there were statistically significant differences(P<0.05).No statistically significant difference was found in the incidence rate of catheter misplacement,hematogenous infection and catheter adherence between the two groups(P>0.05).Conclusion Compared with PICC,TIVAP has fewer complications,longer indwelling time,presenting a preferred option for chemotherapeutic agent infusion for most of the patients with breast cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222